Weak economic data\, healthcare shares pull Wall Street lower

Weak economic data, healthcare shares pull Wall Street lower

Reuters 

By Shreyashi Sanyal

The Commerce Department said new orders for key U.S.-made capital goods unexpectedly fell in December, pointing to a further slowdown in business spending on equipment that could crimp economic growth.

Another set showed the Philadelphia Federal Reserve's gauge on business activity declined in February to its weakest level since May 2016.

The weak numbers threatened to snap the S&P 500's three-day gain, which was driven by signs of progress in trade talks. The index continues to hover near its two-month high.

The and have started to outline commitments in principle on the stickiest issues in their trade dispute, marking the most significant progress yet toward ending a seven-month trade war, sources told on Thursday.

"The data confirms some of the slowdown that we've seen from late last year. It confirms are still leery to go out and invest because of the trade discussions," Ryan Detrick, senior market strategist,

"But the big picture is we've got an enormous rally this year. Markets seem to almost be willing to bypass the weak data that we've seen for the optimism over a resolution on trade."

At 11:27 a.m. ET, the was down 106.28 points, or 0.41 percent, at 25,848.16. The S&P 500 was down 10.62 points, or 0.38 percent, at 2,774.08 and the Composite was down 32.16 points, or 0.43 percent, at 7,456.91.

Eight of the 11 S&P sectors were lower, led by a 0.85 percent decline in after eased from their highs. [O/R]

Dragging the markets lower was a 0.86 percent decline in the sector, weighed down by Johnson & Johnson, which fell 1.1 percent.

The company said it received subpoenas from U.S. regulators related to litigation involving alleged asbestos contamination in its signature product line.

shares fell 3.7 percent after brokerage Stifel downgraded the stock to "hold" from "buy". The Biotech index was down 1.57 percent.

shares dropped 1.7 percent after the company's sneaker worn by emerging basketball star split in half during a game between and

The sportswear maker's shares weighed the most on the consumer discretionary sector, which slipped 0.32 percent

Among gainers, Albermarle's shares jumped 6.2 percent after the posted a higher-than-expected quarterly profit and gave a bullish 2019 outlook.

Declining issues outnumbered advancers for a 1.97-to-1 ratio on the NYSE and for a 1.60-to-1 ratio on the

The S&P index recorded 25 new 52-week highs and no new lows, while the Nasdaq recorded 37 new highs and nine new lows.

(Reporting by and in Bengaluru; Editing by Anil D'Silva)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, February 21 2019. 22:28 IST